The extracorporeal membrane oxygenation systems market is progressing steadily with a CAGR of 5% from 2022-2032, as per the extracorporeal membrane oxygenation systems market analysis by Future Market Insights (FMI).
Recent developments in extracorporeal membrane oxygenation systems market innovations such as miniaturization of ECMO components like hollow pumps, which are used in various surgeries, aids in the transportation of critically ill patients, thereby increasing the ECOM systems market size.
As per the ECOM systems market study, the rising use of ECMO has sparked technological advancements in extracorporeal membrane oxygenation machines of which oxygenators and heparin-coated cannulas are two major emerging trends in the ECOM systems market.
Request a report sample to gain comprehensive insights at
https://www.futuremarketinsights.com/reports/sample/rep-gb-14300
The study finds that extracorporeal membrane oxygenation devices are used in life-threatening situations when other forms of supportive care have failed. Furthermore, the use of ECMO in various healthcare settings has increased significantly owing to its wide range of applications.
| Attributes | Details |
| Extracorporeal Membrane Oxygenation Machine Market CAGR (2022 – 2032) | 5% |
| Extracorporeal Membrane Oxygenation Machine Market (2026) | US$ 643 Bn |
| Extracorporeal Membrane Oxygenation Machine Market Attraction | Huge investment opportunities in Asia Pacific |
The adoption of ECMO procedures is being promoted by several government organizations. One of them is GOLD (Global Initiative for Chronic Obstructive Lung Disease), a campaign that aims to raise awareness about COPD and its treatment, which includes the use of ECMO oxygen machine thereby positively influencing the ECMO systems adoption trends.
The sudden spike in COVID-19 cases, combined with an increase in the number of critically ill patients requiring additional life support, has pushed up demand for ECMO machines. For patients with severe acute respiratory distress syndrome, extracorporeal membrane oxygenation therapy has been the preferred treatment option.
An increasing number of supportive government policies and the rapid FDA approval of extracorporeal membrane oxygenation equipment for emergency use have significantly increased the ECOM systems market opportunities.
Moreover, several companies are scaling up ECOM systems’ market share by expanding their manufacturing capabilities to meet the rising demand for assistive technologies.
On account of the factors mentioned above, the ECOM systems market is predicted to muster a revenue of about US$ 673 Mn by 2026.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14300
Key Takeaways:
- By application, high demand for early diagnosis and diagnostic imaging, and technological advancements in the extracorporeal membrane oxygenation machine market are expected to propel the respiratory segment to the top.
- The arterio-venous segment is likely to hold the majority of the market based on modality owing to the benefits associated with this technology segment, such as effective dynamic range, thereby boosting the ECMO systems market growth.
- Based on patient type, the adult segment is projected to lead the market as the global burden of cardiac and respiratory diseases in adults is rising due to increased consumption of alcohol, tobacco, smoking, and a sedentary lifestyle.
- Based on components, the controller’s segment is expected to dominate the market, and the same can be credited to the systems’ higher adoption among end-users as a result of their lower cost when compared to others.
- The portable ECMO machine segment is expected to dominate the market by product type. They are lightweight and portable, allowing them to be transported to any desired location, influencing the ECMO systems market future trends.
Competitive Landscape:
Companies like Abbott Laboratories, Medtronic, Alung Technologies, and Terumo Corporation dominate the global market.
Major global players produce the majority of ECMO support systems. Market leaders have established their position by investing more in research and having a better distribution system.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14300
To stay competitive in the market, extracorporeal membrane oxygenation machines manufacturers are actively involved in product launches and technological innovation.
- ALung Technologies, Inc. has begun commercialization of its ground-breaking next-generation artificial lung. The device is based on University of Pittsburgh intellectual property licensed to ALung Technologies, Inc.
- Medtronic has released its artificial lung therapy for the treatment of COVID-19. An artificial pump that pumps blood from a person’s body to an oxygenator is called ECMO, and it also has an FDA-approved device for ECMO procedures lasting up to 6 hours.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Medical Vending Machines Market – Medical Vending Machines are the automated machines used to dispense prescription drugs, medical devices and miscellaneous medical products by paying through an interface. The medical vending machines can be installed at a suitable place depending on the utility of the machine.
Veterinary Anesthesia Machines Market – Anesthesia is a type of medicine which is used to control or reduce the pain during surgical procedures. It also helps in breathing, heart rate, blood flow, and blood pressure. General anesthesia fulfills three main objectives i.e. unconsciousness, lack of movement, and blunting of the stress response.
Sputum Ejection Machine Market – Sputum Ejection Machine is a pioneering innovation for various medical applications for healthcare management. Sputum Ejection Machine play a very important role in removing the thick mucus from lungs which is stored inside the lungs.
Immunoadsorption Columns Market – Immunoadsorption columns have been widely employed for the purification of specific antibodies and antigens. In immunoadsorption columns, plasma is removed by apheresis and passed on through an adsorption medium to remove harmful antibodies, following which it is re-infused into the patient.
Acetaminophen Api Market – Acetaminophen API (paracetamol), or Tylenol, is used as in the first-line drug therapy in pain conditions. The API when combined with drug shows antipyretic & analgesics effect.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/